These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34805926)

  • 1. Relationship between circulating tumor cells undergoing EMT and short-term efficacy following interventional treatment in patients with hepatocellular carcinoma.
    Chen M; Xu R; Wu L; Chen X
    J Interv Med; 2020 Sep; 3(3):146-150. PubMed ID: 34805926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
    J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma.
    Chen Y; Li S; Li W; Yang R; Zhang X; Ye Y; Yu J; Ye L; Tang W
    Sci Rep; 2019 May; 9(1):7084. PubMed ID: 31068623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.
    Lei Y; Wang X; Tian Y; Xu R; Pei J; Fu Y; Sun H; Wang Y; Zheng P; Xia F; Wang J
    Front Med (Lausanne); 2023; 10():1209403. PubMed ID: 37841010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
    Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
    Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Zhang Q; Xing W; Zhang J; Hu J; Qi L; Xiang B
    Onco Targets Ther; 2021; 14():1543-1552. PubMed ID: 33688202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
    Shen J; Wang WS; Zhu XL; Ni CF
    J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study.
    Wang PX; Sun YF; Zhou KQ; Cheng JW; Hu B; Guo W; Yin Y; Huang JF; Zhou J; Fan J; Cheung TT; Qu XD; Yang XR
    Clin Transl Med; 2020 Jul; 10(3):e137. PubMed ID: 32702202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Chen Z; Lin X; Chen C; Chen Y; Zhao Q; Wu L; Wang D; Ma Y; Ju W; Chen M; He X
    Ann Transl Med; 2020 Sep; 8(17):1067. PubMed ID: 33145286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status.
    Qi LN; Ma L; Chen YY; Chen ZS; Zhong JH; Gong WF; Lu Y; Xiang BD; Li LQ
    Ann Med; 2020; 52(1-2):21-31. PubMed ID: 31876201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.